OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Your search returned 18 results.    Search:   Expanded Search
Genes match for NM_012313   Similar terms to NM_012313

   KIR2DS3   (NKAT7;NKAT-7;)

 Citation  Cited in Publication(s)

|<<     <<      >>     >>|   total pages:0
SKU   Category   Expression Host   Description   $ Price   Availability  
  TP313617     Protein HEK293 cells Recombinant protein of human killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3 (KIR2DS3) 680 In Stock
  LY415837     Lysate HEK293T Transient overexpression lysate of killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3 (KIR2DS3) 280 5 days
  PH313617     Mass Spec Standard HEK293 KIR2DS3 MS Standard C13 and N15-labeled recombinant protein (NP_036445) 1500 3 weeks
TrueORF Gold TrueORF Gold = Expression Validated + Sequence Verified + Next-day shipment!
SKU   Category   Vector   Tag   Description   $ Price   Availability  
  RC213617     TrueORF Gold TrueORF Gold pCMV6-Entry Myc-DDK KIR2DS3 (Myc-DDK-tagged)-Human killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3 (KIR2DS3) 460 In Stock
  RC213617L1     Human Lenti-ORF pLenti-C-Myc-DDK Myc-DDK Lenti ORF clone of Human killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3 (KIR2DS3) , Myc-DDK-tagged 830
580
2-3 weeks
  RC213617L2     Human Lenti-ORF pLenti-C-mGFP mGFP Lenti ORF clone of Human killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3 (KIR2DS3), mGFP tagged 910
660
2-3 weeks
  RC513617     Human Clone pCMV6-Entry Myc-DDK KIR2DS3 (Myc-DDK-tagged)-Human killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3 (KIR2DS3), (200ug) 580 2~3 weeks
  RG213617     Human Clone pCMV6-AC-GFP TurboGFP KIR2DS3 (GFP-tagged) - Human killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3 (KIR2DS3) 510 In Stock
  SC303957     Human Clone pCMV6-XL5 No Tags KIR2DS3 (untagged)-Human killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3 (KIR2DS3) (10ug) 580 In Stock
SKU   Category   Vector   Description   $ Price   Availability  
  TF311895     Human shRNA pRFP-C-RS KIR2DS3 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector 650 2 Weeks
  TL311895     Human shRNA pGFP-C-shLenti KIR2DS3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 2 Weeks
  TR311895     Human shRNA pRS KIR2DS3 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector 650 2 Weeks
  TG311895     Human shRNA pGFP-V-RS KIR2DS3 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector 650 2 Weeks
  SR302571     Human siRNA KIR2DS3 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each 300
200
In Stock
SKU   Category   Description   $ Price   Availability  
  HP210274     Human Primer qSTAR qPCR primer pairs against Homo sapiens gene KIR2DS3 95 3 - 5 Days
  HK210070     qPCR Standard qPCR primer pairs and template standards against Homo sapiens gene KIR2DS3 390 5 - 7 Days
SKU   Category  
Description   $ Price   Availability  
  SC201995     3'-UTR Clone pMirTarget 3`UTR clone of killer cell immunoglobulin-like receptor two domains short cytoplasmic tail 3 (KIR2DS3) for miRNA target validation 495 3-4 weeks
SKU   Category   Description   $ Price   Availability  
  KN213617     knockout KIR2DS3 - gene knockout kit via CRISPR 1200 4 wks
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title